B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis

BACKGROUND & AIMS: Increased serum IgG and autoantibodies suggest involvement of B cells in autoimmune hepatitis (AIH). The aim of this study was to assess levels of B cell activating factor of the tumour necrosis family (BAFF), IL-21, and circulating B cell populations in AIH and correlate thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Biewenga, Maaike, Heidt, Sebastiaan, Vergunst, Manon, Marijnissen, Camiel M.J., de Man, Rob A., van der Eijk, Annemiek A., van der Meer, Adriaan J., Trouw, Leendert A., van Hoek, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971938/
https://www.ncbi.nlm.nih.gov/pubmed/35368991
http://dx.doi.org/10.1016/j.jhepr.2022.100460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971938/
https://www.ncbi.nlm.nih.gov/pubmed/35368991
http://dx.doi.org/10.1016/j.jhepr.2022.100460

Ejemplares similares